Saint-Herblain and New York, September 28,2021 – Valneva SE, a specialty vaccine company, and Pfizer Inc., announced further positive Phase 2 results, including booster response, for Lyme disease vaccine candidate VLA15.
September 28, 2021
· 11 min read